Use of a Percutaneous Left Ventricular Assist Device for High Risk Percutaneous Coronary Interventions. Clinical Trial versus Real World Experience

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:66

Meeting Abstract

Cohen, Mauricio G.¹  Matthews, Ray V.²  Maini, Brij³  Dixon, Simon⁴  Vetrovec, George W.⁵  Wohns, David H.⁶  Palacios, Igor F.⁷  Popma, Jeffrey⁸  Ohman, E. Magnus⁹  Schreiber, Theodore¹⁰  O'Neill, William W.¹¹ 

[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[2] Univ So Calif, Los Angeles, CA USA

[3] PinnacleHlth Cardiovasc Inst, Wormleysburg, PA USA

[4] Beaumont Hosp, Royal Oak, MI USA

[5] Virginia Commonwealth Univ, Richmond, VA 23284 USA

[6] Frederik Meijer Heart & Vasc Inst Spectrum Hlth, Grand Rapids, MI USA

[7] Massachusetts Gen Hosp, Boston, MA 02114 USA

[8] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[9] Duke Univ, Med Ctr, Durham, NC 27706 USA

[10] Detroit Med Ctr, Cardiovasc Inst, Detroit, MI USA

[11] Henry Ford Hosp, Detroit, MI 48202 USA

关键词: High-risk PCI;    Impella;    Left ventricular assist device;   

DOI  :  10.1016/j.jacc.2015.08.065

来源: Elsevier

【 授权许可】

Free